Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Understanding fibroblast issues in diabetic foot ulcers is key to creating better treatments.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

FFA's causes may include environmental triggers and genetic factors.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Alternating treatment with two drugs could help cells in a rapid aging disease.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Corticosteroids can reduce scarring in acne keloidalis by targeting specific cells.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

EF and PXE not closely related.

Fibrosis contributes to hair loss in androgenetic alopecia, and targeting it may improve treatment.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

A man with hair loss developed a condition causing scarring and inflammation in both bald and non-bald areas of his scalp.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Hair shaft disorders often indicate genetic or systemic issues and are managed by minimizing damage.